WAM
OACC

Warberg Asset Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Warberg Asset Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
10,037
+12
+0.1% +$128 0.02% 135
2026
Q1 		$106K Buy
+10,025
New +$107K 0.02% 136

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Warberg Asset Management's OACC Position: Q2 2026 in Review

Warberg Asset Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 0.12% in Q2 2026, buying an estimated $128 and bringing the position to 10,037 shares worth $107K. The position accounts for 0.02% of the portfolio, ranked #135.

Warberg Asset Management first reported a position in OACC in Q1 2026 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Warberg Asset Management held 10,037 shares of Oaktree Acquisition Corp III Life Sciences worth $107K as of Q2 2026.
  • Warberg Asset Management bought 12 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $128.
  • Oaktree Acquisition Corp III Life Sciences made up 0.02% of Warberg Asset Management's portfolio in Q2 2026, its #135 holding.
  • Warberg Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Warberg Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.